BUILT Biotechnologies, Inc., an emerging leader in DNA Manufacturing-as-a-Service, today announced expanded commercial and manufacturing capabilities and the onboarding of more than 50 new customers ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

With the global technical textiles market heading toward $200B by 2030 , KBLB’s timing could enable early adoption and prototype work for 2026 procurement cycles, especially in high-performance and ...

A Space Odyssey and Gattaca are among the best examples of 20th-century hard sci-fi, grounding their plots in logic and plausibility.

Sam Altman is backing a startup that’s trying to make disease-free babies through gene editing in countries with loose laws.

Disclaimer: The content presented here is for entertainment purposes only and does not guarantee the authenticity or accuracy of the information. The content may contain elements of fiction, ...

Summer McKesson struggled to breathe for years. Doctors told her it was because her blood would not stop clotting – and they couldn’t figure out why. A single clot alone can be lethal; but the ...

Abstract: In today's networked environment, cyber-attacks pose a significant security threat. Traditional port-hopping defense strategies have several limitations: fixed and highly predictable hopping ...

A new study published in Nucleic Acids Research unveils crucial advances in the engineering of CRISPR-associated transposons (CASTs)—a class of natural, RNA-guided DNA integration systems. According ...

Publicly traded companies are increasingly accumulating BNB, the native token of Binance’s layer-1 blockchain BNB Chain. On Wednesday, shares of biotech firm Applied DNA Sciences jumped over 50% ...